Aviwell is a private deep-tech startup using an AI/ML discovery platform at the intersection of life and data sciences. It develops microbiota-based, sustainable nutritional solutions for animal health and performance.
Access to pre-IPO shares is available to accredited investors through UpMarket.
Aviwell shares are not on public exchanges. UpMarket provides accredited investors access through secondary market transactions.
Confirm eligibility under SEC Rule 501 of Regulation D. Income or net worth threshold applies.
Complete KYC/AML onboarding. Typically 1–2 business days. Licensed rep assigned on signup.
Full offering memoranda and risk disclosures provided before any commitment is required.
Review and sign subscription agreement. All documents handled digitally through the platform.
Wire transfer or ACH. $50K minimum. Funds held in custodial account until close.
Pre-IPO investments are illiquid, speculative, and involve risk of total loss of capital.
| Date | Round | PPS (split-adj.) | Valuation |
|---|---|---|---|
| Feb 2024 | Seed | ||
| 2023 | Seed |
Aviwell closed a €11 million Series A round to fund the next phase of growth for its Aneto AI microbiome discovery platform. The round added Blue Revolution Fund, Blast.Club and SWEN Capital Partners as new backers.
Aviwell previously raised €9 million in seed funding, combining venture capital and non-dilutive financing, to accelerate its AI-based discovery platform. The company says Aneto uses data and life-science methods to reprogram the microbiome early in an animal's life.
The company initially focuses on chickens, using AI to identify microbiome mixes linked to faster growth, better feed efficiency and stronger disease resistance. Its founders say the platform could ultimately affect the broader global food chain, with less reliance on antibiotics and steroids.
Interested in Aviwell stock? Fill out the form above or sign up directly. Subject to availability. Accredited investors only.
Request access →UpMarket curates and conducts independent diligence on every investment opportunity before it reaches the platform.
We review every offering's strategy, risk management, liquidity, fees, valuation methodology, tax matters, and all third-party providers — legal counsel, auditor, administrator, and custodian.
We offer investments exclusively from disciplined managers that pursue unique strategies across an array of asset classes.
Our goal is to empower you to build a portfolio that best meets your individual investment objectives.
No. As of March 2026, Aviwell is a private company and does not trade on any public stock exchange. Accredited investors can access Aviwell shares through UpMarket, a FINRA-registered broker-dealer that specializes in pre-IPO investments.
Aviwell does not have a public stock price because it is privately held. The most recent known share price comes from its last funding round. Pre-IPO share prices on the secondary market may differ from the last round price depending on supply, demand, and market conditions.
Yes. Accredited investors can indicate interest in Aviwell shares through UpMarket by filling out the form on this page or creating an account at upmarket.co. All pre-IPO offerings are subject to availability and require a $50,000 minimum investment. UpMarket is a FINRA-registered broker-dealer and has brokered more than $500M in alternative investments since 2019.
Pre-IPO investments carry significant risks. Aviwell shares are illiquid, meaning there is no public market to sell them quickly. There is no guaranteed exit timeline or return. The investment is speculative in nature, and investors should be prepared for the possibility of total loss. Valuations of private companies can fluctuate substantially between funding rounds. Investors should consult their financial advisor and review all offering documents before investing.
In a pre-IPO transaction, accredited investors purchase shares from existing shareholders (such as employees, early investors, or other holders) through secondary market platforms. The company itself does not issue new shares in these transactions. UpMarket facilitates these trades as a FINRA-registered broker-dealer, handling compliance, documentation, and settlement on behalf of both parties.
There are two primary exit paths for pre-IPO holdings: selling your shares on the secondary market to another buyer, or holding until the company completes an IPO or is acquired. Both paths are subject to transfer restrictions, company approval (right of first refusal), and market conditions. The timing of any exit is unpredictable, and investors should plan for a multi-year holding period.
The minimum investment for most pre-IPO offerings on UpMarket is $50,000. This amount may vary depending on the specific offering and share availability. There are no fees to create an UpMarket account or browse available investments. Investors only pay transaction-related fees when they complete an investment.
UpMarket's valuation estimate of is derived from a proprietary model that incorporates multiple data sources: funding round data (Caplight), revenue estimates (Sacra), secondary market pricing, and public company comparables. The model applies a private company discount to the public comp multiple to account for illiquidity and information asymmetry. This estimate is not investment advice and may differ substantially from the price at which shares actually trade.
Aviwell is a private deep-tech startup applying an AI/ML discovery platform to microbiota-based sustainable nutritional solutions and raised €11m in its Series A to scale Aneto AI, — accredited investors can access Aviwell stock through UpMarket.